+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nephrotic Syndrome (NS) Etiologies - Epidemiology Forecast to 2028

  • ID: 4845148
  • Report
  • September 2019
  • Region: Global
  • 80 pages
  • DelveInsight
1 of 2
‘Nephrotic Syndrome (NS) Etiologies - Epidemiology Forecast to 2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Nephrotic Syndrome (NS) across all etiologies in the United States for period of 2014-2028.

Geography Covered
  • The United States
Study Period:2014-2028

Nephrotic Syndrome (NS) - Disease Understanding

Nephrotic syndrome (NS) is a clinical syndrome defined by massive proteinuria (greater than 40 mg/m2 per hour) responsible for hypoalbuminemia (less than 30 g/L), with resulting hyperlipidemia, edema, and various complications. It is caused by increased permeability through the damaged basement membrane in the renal glomerulus especially infectious or thromboembolic.

Nephrotic Syndrome Epidemiology

The Nephrotic Syndrome epidemiology division provide the insights about historical and current patient pool and forecasted trend in The United States across various etiologies. The epidemiology data for Nephrotic Syndrome are categorized through all possible etiology to give a better understanding about the Disease scenario in the United States. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Nephrotic Syndrome Epidemiology Segmentation
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total Incident population, total prevalent cases) scenario of Nephrotic Syndrome across etiologies such as Primary Glomerulonephropathies, Secondary Glomerulonephropathies, Focal Segmental Glomerulosclerosis (FSGS), Membranous nephropathy (MGN),and others in the United States from 2014-2028.

The Report also provides the epidemiology trends observed in the United States during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this report, the total number of prevalent cases of Nephrotic Syndrome in United States was found to be 425,532 in the year 2014.

Report Scope
  • The report covers detailed overview of Nephrotic Syndrome explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Nephrotic Syndrome in the United States
  • The Report assesses the risk and burden of the disease
  • The Report helps to recognize the growth opportunities in the United States with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by prevalence and incidence of Nephrotic Syndrome across all etiologies in the United States.
Key Strengths
  • 10 Year Forecast of Nephrotic Syndrome epidemiology
  • United States
  • Total Prevalent Cases of Nephrotic Syndrome
  • Total Incident Cases of Nephrotic Syndrome
  • Prevalent and Incident Cases according to Etiologies: Primary Glomerulonephropathies, Secondary Glomerulonephropathies, Focal Segmental Glomerulosclerosis (FSGS), Membranous nephropathy (MGN), Idiopathic membranous nephropathy (IMN), Minimal-change nephropathy (MCD), IgA Nephropathy, Membrano-proliferative glomerulonephritis (MPGN), Fibrillary Glomerulonephritis (FGN), Immunotactoid Glomerulopathy (ITG), and others.
Key Assessments
  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
Note: Product cover images may vary from those shown
2 of 2
1. Nephrotic Syndrome: Disease Background and Overview
1.1. Introduction
1.2. Causes
1.3. Symptoms
1.3.1. Symptoms of Acute Nephrotic Syndrome
1.3.2. Symptoms of Chronic Nephrotic Syndrome
1.3.3. Complications of Nephrotic Syndrome
1.4. Diagnosis
1.4.1. Goals
1.4.2. Diagnostic Procedures
1.4.2.1. Other diagnostic procedures for NS associated conditions
1.4.3. Diagnostic Algorithm
1.5. Classification
1.6. Pathophysiology
1.6.1. Pathophysiology of acute renal failure in the Nephrotic Syndrome
1.6.2. Pathophysiology of Edema Formation in the Nephrotic Syndrome
1.6.3. Pathophysiology of Minimal Change Nephrotic Syndrome and Focal Segmental Glomerulosclerosis
1.7. Etiology of Nephrotic Syndrome
1.7.1. Primary causes
1.7.2. Secondary causes

2. Epidemiology and Patient Population - The United States
2.1. KOL Views
2.2. Key Findings
2.3. Nephrotic Syndrome Epidemiology Trends
2.4. Assumptions and Rationale
2.5. Incidence of Nephrotic Syndrome across all etiologies
2.6. Prevalence of Nephrotic Syndrome across all etiologies

3. Epidemiology of Nephrotic Syndrome in the United States
3.1. Incident Cases of Nephrotic Syndrome
3.1.1. Incident Cases of Nephrotic Syndrome by primary and secondary etiologies
3.1.2. Incident Cases of Primary Idiopathic Nephrotic Syndrome across all etiologies
3.1.3. Incident Cases of Primary Glomerulonephropathies
3.1.4. Incident Cases of Secondary Glomerulonephropathies
3.1.5. Incident Cases of Focal Segmental Glomerulosclerosis (FSGS)
3.1.6. Incident Cases of Membranous nephropathy (MGN)
3.1.7. Incident Cases of Idiopathic membranous nephropathy (IMN)
3.1.8. Incident Cases of Minimal-¬change nephropathy (MCD)
3.1.9. Incident Cases of IgA Nephropathy
3.1.10. Incident Cases of Membrano-proliferative glomerulonephritis (MPGN)
3.1.11. Incident Cases of Fibrillary Glomerulonephritis (FGN)
3.1.11.1. Incident Cases of Immunotactoid Glomerulopathy (ITG)
3.1.12. Incident Cases of other etiologies
3.2. Prevalent Cases of Nephrotic Syndrome
3.2.1. Prevalent Cases of Nephrotic Syndrome by primary and secondary etiologies
3.2.2. Prevalent Cases of Nephrotic Syndrome across all etiologies
3.2.3. Prevalent Cases of Primary Glomerulonephropathies
3.2.4. Prevalent Cases of Secondary Glomerulonephropathies
3.2.5. Prevalent Cases of Focal Segmental Glomerulosclerosis (FSGS)
3.2.6. Prevalent Cases of Membranous nephropathy (MGN)
3.2.7. Prevalent Cases of Idiopathic membranous nephropathy (IMN)
3.2.8. Prevalent Cases of Minimal-¬change nephropathy (MCD)
3.2.9. Prevalent Cases of IgA Nephropathy
3.2.10. Prevalent Cases of Membrano-proliferative glomerulonephritis (MPGN)
3.2.11. Prevalent Cases of Fibrillary Glomerulonephritis (FGN)
3.2.12. Prevalent Cases of Immunotactoid Glomerulopathy (ITG)
3.2.13. Prevalent Cases of other etiologies

4. Treatment
4.1. Routinely Prescribed Therapeutics for NS
4.2. General Treatment Measures
4.3. Treatment Guidelines for Nephrotic Syndrome

5. KDIGO Guidelines for Nephrotic Syndrome

6. Appendix
6.1. Report Methodology

7. Capabilities

8. Disclaimer

9. About the Publisher
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll